ANIX Anixa Biosciences Inc Fiscal Quarter-End Dates

Non-calendar fiscal year

“During the fiscal year ended October 31, 2025, cash used in operating activities was approximately $7,173,000.”

Anixa Biosciences Inc Form 10-K, filed Jan 12, 2026 — SEC EDGAR

Quarter-End Dates

Period Quarter End Days Filing
FY2022 Q2 Apr 30, 2022 89 10-Q, Jun 10, 2022
FY2022 Q3 Jul 31, 2022 92 10-Q, Sep 9, 2022
FY2022 Q4 Oct 31, 2022 92 10-K, Jan 4, 2023
FY2023 Q1 Jan 31, 2023 92 10-Q, Mar 17, 2023
FY2023 Q2 Apr 30, 2023 89 10-Q, Jun 14, 2023
FY2023 Q3 Jul 31, 2023 92 10-Q, Sep 6, 2023
FY2023 Q4 Oct 31, 2023 92 10-K, Jan 16, 2024
FY2024 Q1 Jan 31, 2024 92 10-Q, Mar 12, 2024
FY2024 Q2 Apr 30, 2024 90 10-Q, Jun 4, 2024
FY2024 Q3 Jul 31, 2024 92 10-Q, Sep 6, 2024
FY2024 Q4 Oct 31, 2024 92 10-K, Jan 10, 2025
FY2025 Q1 Jan 31, 2025 92 10-Q, Mar 11, 2025
FY2025 Q2 Apr 30, 2025 89 10-Q, May 28, 2025
FY2025 Q3 Jul 31, 2025 92 10-Q, Sep 10, 2025
FY2025 Q4 Oct 31, 2025 92 10-K, Jan 12, 2026
FY2026 Q1 Jan 31, 2026 92 10-Q, Mar 9, 2026
FY2026 Q2 projected Apr 30, 2026 89 —
FY2026 Q3 projected Jul ??, 2026 —
FY2026 Q4
FY2027 Q1
FY2027 Q2

Need the next projected quarter-end date? TrueQuarter tracks board-approved fiscal calendar changes from 8-K filings to deliver survivorship-bias-free, point-in-time data.

Request a sample for ANIX →